3D printing of PVA capsular devices for modified drug delivery: design and in vitro dissolution studies

References

• Liang K, Brambilla D, Leroux JC. Is 3D printing of pharmaceuticals a disruptor or enabler? Adv Mater. 2019;31:1805680–1805684.
   Web of Science ®Google Scholar
• T U, M M. Three dimensional (3D) drug printing: a revolution in pharmaceutical science. PharmaTutor. 2019;7:19.
   Google Scholar
• Prasad LK, Smyth H. 3D Printing technologies for drug delivery: a review. Drug Dev Ind Pharm. 2015;9045:1–13.
   Google Scholar
• Trenfield SJ, Awad A, Goyanes A, et al. 3D printing pharmaceuticals: drug development to frontline care. Trends Pharmacol Sci. 2018;39:440–451.
   PubMed Web of Science ®Google Scholar
• Souto EB, Campos JC, Filho SC, et al. 3D printing in the design of pharmaceutical dosage forms. Pharm Dev Technol. 2019;24:1044–1053.
   PubMed Web of Science ®Google Scholar
• Gioumouxouzis CI, Karavasili C, Fatouros DG. Recent advances in pharmaceutical dosage forms and devices using additive manufacturing technologies. Drug Discov Today. 2019;24:636–643.
   PubMed Web of Science ®Google Scholar
• Joo Y, Shin I, Ham G, et al. The advent of a novel manufacturing technology in pharmaceutics: superiority of fused deposition modeling 3D printer. J Pharm Investig. 2020;50:131–145.
   Google Scholar
• Mazzanti V, Malagutti L, Mollica F. FDM 3D printing of polymers containing natural fillers: a review of their mechanical properties. Polymers (Basel). 2019;11:1094.
   PubMed Web of Science ®Google Scholar
• Jamróz W, Szafraniec J, Kurek M, et al. 3D printing in pharmaceutical and medical applications. Pharm Res. 2018;35:176.
   PubMed Web of Science ®Google Scholar
• Okwuosa TC, Pereira BC, Arafat B, et al. Fabricating a shell-core delayed release tablet using dual FDM 3D printing for patient-centred therapy. Pharm Res. 2017;34:427–437.
   PubMed Web of Science ®Google Scholar
• Azad MA, Olawuni D, Kimbell G, et al. Polymers for extrusion-based 3D printing of pharmaceuticals: a holistic materials–process perspective. Pharmaceutics. 2020;12:124–134.
   PubMed Web of Science ®Google Scholar
• Matijašić G, Gretić M, Vinčić J, et al. Design and 3D printing of multi-compartmental PVA capsules for drug delivery. J Drug Deliv Sci Technol. 2019;52:677–686.
   Web of Science ®Google Scholar
• Goyanes A, Buanz ABM, Basit AW, et al. Fused-filament 3D printing (3DP) for fabrication of tablets. Int J Pharm. 2014;476:88–92.
   PubMed Web of Science ®Google Scholar
• Goyanes A, Buanz ABM, Hatton GB, et al. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets. Eur J Pharm Biopharm. 2015;89:157–162.
   PubMed Web of Science ®Google Scholar
• Skowyra J, Pietrzak K, Alhnan MA. Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. Eur J Pharm Sci. 2015;68:11–17.
   PubMed Web of Science ®Google Scholar
• Tagami T, Fukushige K, Ogawa E, et al. 3D printing factors important for the fabrication of polyvinylalcohol filament-based tablets. Biol Pharm Bull. 2017;40:357–364.
   PubMed Web of Science ®Google Scholar
• Goyanes A, Chang H, Sedough D, et al. Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing. Int J Pharm. 2015;496:414–420.
   PubMed Web of Science ®Google Scholar
• Goyanes A, Kobayashi M, Martínez-Pacheco R, et al Fused-filament 3D printing of drug products: microstructure analysis and drug release characteristics of PVA-based caplets. Int J Pharm. 2016;514:290–295.
   PubMedGoogle Scholar
• Li Q, Wen H, Jia D, et al. Preparation and investigation of controlled-release glipizide novel oral device with three-dimensional printing. Ind J Pharm. 2017;525:5–11.
   Google Scholar
• Melocchi A, Uboldi M, Maroni A, et al 3D printing by fused deposition modeling of single- and multi-compartment hollow systems for oral delivery – a review. Int J Pharm. 2020;579:119155.
   PubMedGoogle Scholar
• Melocchi A, Parietti F, Loreti G, et al. 3D printing by fused deposition modeling (FDM) of a swellable/erodible capsular device for oral pulsatile release of drugs. J Drug Deliv Sci Technol. 2015;30:360–367.
   Web of Science ®Google Scholar
• Maroni A, Melocchi A, Parietti F, et al. 3D printed multi-compartment capsular devices for two-pulse oral drug delivery. J Control Release. 2017;268:10–18.
   PubMed Web of Science ®Google Scholar
• Kempin W, Domsta V, Brecht I, et al. Development of a dual extrusion printing technique for an acid- and thermo-labile drug. Eur J Pharm Sci. 2018;123:191–198.
   PubMed Web of Science ®Google Scholar
• Okwuosa TC, Soares C, Gollwitzer V, et al. On demand manufacturing of patient-specific liquid capsules via co-ordinated 3D printing and liquid dispensing. Eur J Pharm Sci. 2018;118:134–143.
   PubMed Web of Science ®Google Scholar
• Krause J, Bogdahn M, Schneider F, et al. Design and characterization of a novel 3D printed pressure-controlled drug delivery system. Eur J Pharm Sci. 2019;140:105060.
   PubMed Web of Science ®Google Scholar
• Smith DM, Kapoor Y, Klinzing GR, et al. Pharmaceutical 3D printing: design and qualification of a single step print and fill capsule. Int J Pharm. 2018;544:21–30.
   PubMed Web of Science ®Google Scholar
• Markl D, Zeitler JA, Rasch C, et al Analysis of 3D prints by X-ray computed microtomography and terahertz pulsed imaging. Pharm Res. 2017;34:1037–1052.
   PubMed Web of Science ®Google Scholar
• Siamidi A, Pippa Ν, Demetzos C. Pharmaceutical compounding: Recent advances, lessons learned and future perspectives. Glob Drugs Ther. 2017;2:1–3.
   Google Scholar
• Dooms M, Carvalho M. Compounded medication for patients with rare diseases. Orphanet J Rare Dis. 2018;13:1–8.
   PubMed Web of Science ®Google Scholar
• Araújo MRP, Sa-Barreto LL, Gratieri T, et al. The digital pharmacies era: How 3D printing technology using fused deposition modeling can become a reality. Pharmaceutics. 2019;11:128.
   Web of Science ®Google Scholar
• Pithadia AB, Jain S. Treatment of inflammatory bowel disease (IBD. Pharmacol. Reports. 2011;63:629–642.
   PubMed Web of Science ®Google Scholar
• Castells M, Butterfield J. Mast cell activation syndrome and mastocytosis: initial treatment options and long-term management. J Allergy Clin Immunol Pract. 2019;7:1097–1106.
   PubMed Web of Science ®Google Scholar
• Leal Mora E, Serrano Lopez D, Sureda Domingo E. Intervención farmacia-universidad-asociación de pacientes para evaluar la estabilidad de fórmulas magistrales de cromoglicato. VIII Congr. Nac. Farm. Comunitarios, Alicante, Spain, 2018.
   Google Scholar
• OnShape. OnShape. 2018. Available from: https://www.onshape.com/
   Google Scholar
• Repetier, Hot-World GmbH & Co. KG. 2019. Available from: https://www.repetier.com/
   Google Scholar
• USP, United States Pharmacopeia and National Formulary (USP 41-NF36). United States Pharmacopeia and National Formulary. Rockville (MD); 2018.
   Google Scholar
• Diaz DA, Colgan ST, Langer CS, et al. Dissolution similarity requirements: how similar or dissimilar are the global regulatory expectations? AAPS J. 2016;18:15–22.
   PubMed Web of Science ®Google Scholar
• Langenbucher F. Linearization of dissolution rate curves by the Weibull distribution. J Pharm Pharmacol. 1972;24:979–981.
   PubMed Web of Science ®Google Scholar
• Sathe PM, Tsong Y, Shah VP. In-vitro dissolution profile comparison: statistics and analysis, model dependent approach. Pharm Res. 1996;13:1799–1803.
   PubMed Web of Science ®Google Scholar
• Tsong Y, Hammerstrom T, Chen JJ. Multipoint dissolution specification and acceptance sampling rule based on profile modeling and principal component analysis. J Biopharm Stat. 1997;7:423–439.
   PubMedGoogle Scholar
• Zhang Y, Huo M, Zhou J, et al. DDSolver : an add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 2010;12:263–271.
   PubMed Web of Science ®Google Scholar
• Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974;19:716–723.
   Web of Science ®Google Scholar
• Wei C, Solanki NG, Vasoya JM, et al. Development of 3D printed tablets by fused deposition modeling using polyvinyl alcohol as polymeric matrix for rapid drug release. J Pharm Sci. 2020;109:1558–1572.
   PubMed Web of Science ®Google Scholar
• Smith D, Kapoor Y, Hermans A, et al. 3D printed capsules for quantitative regional absorption studies in the GI tract. Int J Pharm. 2018;550:418–428.
   PubMed Web of Science ®Google Scholar
• Todaro V, Persoons T, Grove G, et al. Characterization and simulation of hydrodynamics in the paddle, basket and flow-through dissolution testing apparatuses – a review. Dissolution Technol. 2017;24:24–36.
   Web of Science ®Google Scholar
• Huanbutta K, Sangnim T. Design and development of zero-order drug release gastroretentive floating tablets fabricated by 3D printing technology. J Drug Deliv Sci Technol. 2019;52:831–837.
   Web of Science ®Google Scholar
• Charoenying T, Patrojanasophon P, Ngawhirunpat T, et al. Fabrication of floating capsule-in- 3D-printed devices as gastro-retentive delivery systems of amoxicillin. J Drug Deliv Sci Technol. 2020;55:101393.
   Web of Science ®Google Scholar
• The science and practice of pharmacy. 21st ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2005.
   Google Scholar